• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Src 家族激酶 LCK 与致癌性 FLT3/ITD 协同作用促进细胞转化。

The Src family kinase LCK cooperates with oncogenic FLT3/ITD in cellular transformation.

机构信息

Division of Translational Cancer Research, Department of Laboratory Medicine, Lund University, Medicon Village, Lund, Sweden.

Lund Stem Cell Center, Department of Laboratory Medicine, Lund University, Lund, Sweden.

出版信息

Sci Rep. 2017 Oct 23;7(1):13734. doi: 10.1038/s41598-017-14033-4.

DOI:10.1038/s41598-017-14033-4
PMID:29062038
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5653865/
Abstract

The non-receptor tyrosine kinase LCK belongs to the SRC family of kinases. SRC family kinases are proto-oncogenes that have long been known to play key roles in cell proliferation, motility, morphology and survival. Here we show that LCK regulates the function of the type III receptor tyrosine kinase FLT3 in murine pro-B cells. We observed that expression of LCK significantly enhances the colony forming capacity of the constitutively active FLT3 mutant FLT3-ITD (internal tandem duplication). Furthermore, cells expressing LCK developed tumor earlier compared to cells transfected with empty control vector. Staining of the tissues from mouse xenografts showed higher Ki67 staining in cells expressing LCK suggesting that expression of LCK enhances the FLT3-ITD-mediated proliferative capacity. LCK expression did not affect either FLT3-WT or FLT3-ITD -induced AKT, ERK1/2 or p38 phosphorylation. However, LCK expression significantly enhanced FLT3-ITD-mediated STAT5 phosphorylation. Taken together, our data suggest that LCK cooperates with oncogenic FLT3-ITD in cellular transformation.

摘要

非受体酪氨酸激酶 LCK 属于 SRC 家族激酶。SRC 家族激酶是原癌基因,长期以来一直被认为在细胞增殖、运动性、形态和存活中发挥关键作用。在这里,我们表明 LCK 调节鼠前 B 细胞中 III 型受体酪氨酸激酶 FLT3 的功能。我们观察到 LCK 的表达显著增强了组成性激活的 FLT3 突变体 FLT3-ITD(内部串联重复)的集落形成能力。此外,与转染空载体的细胞相比,表达 LCK 的细胞更早地形成肿瘤。对来自小鼠异种移植物的组织进行染色显示,表达 LCK 的细胞中 Ki67 染色更高,这表明 LCK 的表达增强了 FLT3-ITD 介导的增殖能力。LCK 表达不影响 FLT3-WT 或 FLT3-ITD 诱导的 AKT、ERK1/2 或 p38 磷酸化。然而,LCK 表达显著增强了 FLT3-ITD 介导的 STAT5 磷酸化。总之,我们的数据表明 LCK 与致癌性 FLT3-ITD 协同作用于细胞转化。

相似文献

1
The Src family kinase LCK cooperates with oncogenic FLT3/ITD in cellular transformation.Src 家族激酶 LCK 与致癌性 FLT3/ITD 协同作用促进细胞转化。
Sci Rep. 2017 Oct 23;7(1):13734. doi: 10.1038/s41598-017-14033-4.
2
FYN expression potentiates FLT3-ITD induced STAT5 signaling in acute myeloid leukemia.FYN表达增强急性髓系白血病中FLT3-ITD诱导的STAT5信号传导。
Oncotarget. 2016 Mar 1;7(9):9964-74. doi: 10.18632/oncotarget.7128.
3
Internal tandem duplication mutations in the tyrosine kinase domain of FLT3 display a higher oncogenic potential than the activation loop D835Y mutation.FLT3酪氨酸激酶结构域中的内部串联重复突变比激活环D835Y突变显示出更高的致癌潜能。
Ann Hematol. 2018 May;97(5):773-780. doi: 10.1007/s00277-018-3245-5. Epub 2018 Jan 25.
4
Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathways.急性髓系白血病患者的Flt3突变通过Ras和STAT5信号通路诱导32D细胞发生转化。
Blood. 2000 Dec 1;96(12):3907-14.
5
Pim2 complements Flt3 wild-type receptor in hematopoietic progenitor cell transformation.Pim2在造血祖细胞转化中补充Flt3野生型受体。
Leukemia. 2008 Jan;22(1):78-86. doi: 10.1038/sj.leu.2404988. Epub 2007 Oct 18.
6
Wild-type FLT3 and FLT3 ITD exhibit similar ligand-induced internalization characteristics.野生型 FLT3 和 FLT3 ITD 表现出相似的配体诱导内化特征。
J Cell Mol Med. 2020 Apr;24(8):4668-4676. doi: 10.1111/jcmm.15132. Epub 2020 Mar 10.
7
Activation mechanisms of STAT5 by oncogenic Flt3-ITD.致癌性Flt3-ITD对STAT5的激活机制
Blood. 2007 Jul 1;110(1):370-4. doi: 10.1182/blood-2006-05-024018. Epub 2007 Mar 13.
8
Tyrosine 842 in the activation loop is required for full transformation by the oncogenic mutant FLT3-ITD.致癌突变体FLT3-ITD的完全转化需要激活环中的酪氨酸842。
Cell Mol Life Sci. 2017 Jul;74(14):2679-2688. doi: 10.1007/s00018-017-2494-0. Epub 2017 Mar 7.
9
Lyn is an important component of the signal transduction pathway specific to FLT3/ITD and can be a therapeutic target in the treatment of AML with FLT3/ITD.Lyn是FLT3/ITD特异性信号转导通路的重要组成部分,可成为治疗伴有FLT3/ITD的急性髓系白血病的治疗靶点。
Leukemia. 2007 Mar;21(3):403-10. doi: 10.1038/sj.leu.2404547. Epub 2007 Jan 18.
10
SRC is a signaling mediator in FLT3-ITD- but not in FLT3-TKD-positive AML.SRC 是 FLT3-ITD-阳性但不是 FLT3-TKD-阳性 AML 中的信号转导介质。
Blood. 2012 Apr 26;119(17):4026-33. doi: 10.1182/blood-2011-07-365726. Epub 2012 Mar 12.

引用本文的文献

1
Non-Receptor Tyrosine Kinases: Their Structure and Mechanistic Role in Tumor Progression and Resistance.非受体酪氨酸激酶:它们在肿瘤进展和耐药中的结构及机制作用
Cancers (Basel). 2024 Aug 2;16(15):2754. doi: 10.3390/cancers16152754.
2
A Novel Peptide that Disrupts the Lck-IPR Protein-Protein Interaction Induces Widespread Cell Death in Leukemia and Lymphoma.一种破坏Lck-IPR蛋白-蛋白相互作用的新型肽在白血病和淋巴瘤中诱导广泛的细胞死亡。
Arch Microbiol Immunol. 2023;7(3):165-177. doi: 10.26502/ami.936500114. Epub 2023 Aug 30.
3
Alterations in cellular metabolisms after TKI therapy for Philadelphia chromosome-positive leukemia in children: A review.儿童费城染色体阳性白血病接受酪氨酸激酶抑制剂治疗后细胞代谢的改变:综述
Front Oncol. 2022 Dec 6;12:1072806. doi: 10.3389/fonc.2022.1072806. eCollection 2022.
4
Radotinib attenuates TGFβ -mediated pulmonary fibrosis in vitro and in vivo: exploring the potential of drug repurposing.来那替尼在体外和体内减轻转化生长因子β介导的肺纤维化:探索药物重新利用的潜力。
BMC Pharmacol Toxicol. 2022 Dec 15;23(1):93. doi: 10.1186/s40360-022-00634-x.
5
Inferring tumor-specific cancer dependencies through integrating ex vivo drug response assays and drug-protein profiling.通过整合体外药物反应测定和药物蛋白谱分析推断肿瘤特异性癌症相关性。
PLoS Comput Biol. 2022 Aug 22;18(8):e1010438. doi: 10.1371/journal.pcbi.1010438. eCollection 2022 Aug.
6
T cell receptor (TCR) signaling in health and disease.T 细胞受体 (TCR) 在健康和疾病中的信号转导。
Signal Transduct Target Ther. 2021 Dec 13;6(1):412. doi: 10.1038/s41392-021-00823-w.
7
New horizons in drug discovery of lymphocyte-specific protein tyrosine kinase (Lck) inhibitors: a decade review (2011-2021) focussing on structure-activity relationship (SAR) and docking insights.淋巴细胞特异性蛋白酪氨酸激酶 (Lck) 抑制剂药物发现的新领域:十年综述 (2011-2021),重点关注结构-活性关系 (SAR) 和对接见解。
J Enzyme Inhib Med Chem. 2021 Dec;36(1):1574-1602. doi: 10.1080/14756366.2021.1937143.
8
Identification of Prognosis-Related Genes in Bladder Cancer Microenvironment across TCGA Database.膀胱癌微环境中与预后相关基因的鉴定——基于 TCGA 数据库。
Biomed Res Int. 2020 Nov 3;2020:9143695. doi: 10.1155/2020/9143695. eCollection 2020.
9
Preclinical efficacy for a novel tyrosine kinase inhibitor, ArQule 531 against acute myeloid leukemia.新型酪氨酸激酶抑制剂 ArQule 531 治疗急性髓系白血病的临床前疗效。
J Hematol Oncol. 2020 Jan 28;13(1):8. doi: 10.1186/s13045-019-0821-7.
10
Targeting Tyrosine Kinases in Acute Myeloid Leukemia: Why, Who and How?靶向治疗急性髓系白血病的酪氨酸激酶:为何、针对谁及如何治疗?
Int J Mol Sci. 2019 Jul 12;20(14):3429. doi: 10.3390/ijms20143429.

本文引用的文献

1
Tyrosine 842 in the activation loop is required for full transformation by the oncogenic mutant FLT3-ITD.致癌突变体FLT3-ITD的完全转化需要激活环中的酪氨酸842。
Cell Mol Life Sci. 2017 Jul;74(14):2679-2688. doi: 10.1007/s00018-017-2494-0. Epub 2017 Mar 7.
2
ABL2 suppresses FLT3-ITD-induced cell proliferation through negative regulation of AKT signaling.ABL2通过对AKT信号通路的负调控来抑制FLT3-ITD诱导的细胞增殖。
Oncotarget. 2017 Feb 14;8(7):12194-12202. doi: 10.18632/oncotarget.14577.
3
Src-like adaptor protein 2 (SLAP2) binds to and inhibits FLT3 signaling.Src样衔接蛋白2(SLAP2)与FLT3信号传导结合并抑制其信号传导。
Oncotarget. 2016 Sep 6;7(36):57770-57782. doi: 10.18632/oncotarget.10760.
4
An essential pathway links FLT3-ITD, HCK and CDK6 in acute myeloid leukemia.在急性髓系白血病中,一条关键途径将FLT3-ITD、HCK和CDK6联系起来。
Oncotarget. 2016 Aug 9;7(32):51163-51173. doi: 10.18632/oncotarget.9965.
5
Expression of GADS enhances FLT3-induced mitogenic signaling.GADS的表达增强了FLT3诱导的促有丝分裂信号传导。
Oncotarget. 2016 Mar 22;7(12):14112-24. doi: 10.18632/oncotarget.7415.
6
FYN expression potentiates FLT3-ITD induced STAT5 signaling in acute myeloid leukemia.FYN表达增强急性髓系白血病中FLT3-ITD诱导的STAT5信号传导。
Oncotarget. 2016 Mar 1;7(9):9964-74. doi: 10.18632/oncotarget.7128.
7
The Phosphatases STS1 and STS2 Regulate Hematopoietic Stem and Progenitor Cell Fitness.磷酸酶 STS1 和 STS2 调节造血干/祖细胞适应性。
Stem Cell Reports. 2015 Oct 13;5(4):633-46. doi: 10.1016/j.stemcr.2015.08.006. Epub 2015 Sep 10.
8
BEX1 acts as a tumor suppressor in acute myeloid leukemia.BEX1在急性髓系白血病中发挥肿瘤抑制作用。
Oncotarget. 2015 Aug 28;6(25):21395-405. doi: 10.18632/oncotarget.4095.
9
Identification of potential therapeutic target genes, key miRNAs and mechanisms in acute myeloid leukemia based on bioinformatics analysis.基于生物信息学分析鉴定急性髓系白血病潜在治疗靶点基因、关键微小RNA及机制
Med Oncol. 2015 May;32(5):152. doi: 10.1007/s12032-015-0572-4. Epub 2015 Apr 2.
10
Role of SRC-like adaptor protein (SLAP) in immune and malignant cell signaling.Src 样衔接蛋白(SLAP)在免疫细胞和恶性细胞信号传导中的作用。
Cell Mol Life Sci. 2015 Jul;72(13):2535-44. doi: 10.1007/s00018-015-1882-6. Epub 2015 Mar 13.